Point72 Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
TCM
Point72 Asset Management's BLUE Position: Q1 2024 in Review
Point72 Asset Management sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 29,220 shares — an estimated $806K sold.
Point72 Asset Management first reported a position in BLUE in Q2 2014 and held it in 17 quarters. The position peaked at $34.9M in Q2 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Point72 Asset Management reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Point72 Asset Management sold 29,220 bluebird bio shares in Q1 2024, an estimated $806K.
- Point72 Asset Management first reported a position in bluebird bio in Q2 2014 and held it in 17 quarters.
- Point72 Asset Management's bluebird bio position peaked at $34.9M in Q2 2015.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.